These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34981329)

  • 1. Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985-2016.
    Miyamoto S; Umeda K; Kurata M; Yanagimachi M; Iguchi A; Sasahara Y; Okada K; Koike T; Tanoshima R; Ishimura M; Yamada M; Sato M; Takahashi Y; Kajiwara M; Kawaguchi H; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
    J Clin Immunol; 2022 Apr; 42(3):529-545. PubMed ID: 34981329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic Cell Transplantation for Severe Combined Immunodeficiency Patients: a Japanese Retrospective Study.
    Miyamoto S; Umeda K; Kurata M; Nishimura A; Yanagimachi M; Ishimura M; Sato M; Shigemura T; Kato M; Sasahara Y; Iguchi A; Koike T; Takahashi Y; Kajiwara M; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
    J Clin Immunol; 2021 Nov; 41(8):1865-1877. PubMed ID: 34448087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
    Dvorak CC; Hassan A; Slatter MA; Hönig M; Lankester AC; Buckley RH; Pulsipher MA; Davis JH; Güngör T; Gabriel M; Bleesing JH; Bunin N; Sedlacek P; Connelly JA; Crawford DF; Notarangelo LD; Pai SY; Hassid J; Veys P; Gennery AR; Cowan MJ
    J Allergy Clin Immunol; 2014 Oct; 134(4):935-943.e15. PubMed ID: 25109802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.
    Nishimura A; Miyamoto S; Imai K; Morio T
    Int J Hematol; 2022 Jul; 116(1):7-15. PubMed ID: 35675025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
    Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
    J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity.
    Miyamoto S; Niizato D; Tomomasa D; Nishimura A; Hoshino A; Kamiya T; Isoda T; Takagi M; Kajiwara M; Azumi S; Hirabayashi S; Sakamoto K; Kishimoto K; Miyamura T; Umeda K; Hirose A; Keino D; Yanagimachi M; Kanda K; Sakai Y; Ikawa Y; Watanabe K; Tanaka K; Mori T; Ichinohe T; Sakaguchi H; Morio T; Kanegane H
    J Clin Immunol; 2024 May; 44(6):126. PubMed ID: 38773000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders.
    Gupta A; Downey M; Shanley R; Jennissen C; Miller WP; Lund TC; Orchard PJ; Smith AR
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):486-492. PubMed ID: 31751770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
    Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
    Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifelong Immune Modulation Versus Hematopoietic Cell Therapy for Inborn Errors of Immunity.
    Cooper MA; Zimmerman O; Nataraj R; Wynn RF
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):628-639. PubMed ID: 33551038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome.
    Hama A; Taga T; Tomizawa D; Muramatsu H; Hasegawa D; Adachi S; Yoshida N; Noguchi M; Sato M; Okada K; Koh K; Mitsui T; Takahashi Y; Miyamura T; Hashii Y; Kato K; Atsuta Y; Okamoto Y
    Br J Haematol; 2023 May; 201(4):747-756. PubMed ID: 36786154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.
    Konuma T; Kato S; Oiwa-Monna M; Ishii H; Tojo A; Takahashi S
    Leuk Lymphoma; 2016 Sep; 57(9):2126-32. PubMed ID: 26769297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.
    Hassan A; Booth C; Brightwell A; Allwood Z; Veys P; Rao K; Hönig M; Friedrich W; Gennery A; Slatter M; Bredius R; Finocchi A; Cancrini C; Aiuti A; Porta F; Lanfranchi A; Ridella M; Steward C; Filipovich A; Marsh R; Bordon V; Al-Muhsen S; Al-Mousa H; Alsum Z; Al-Dhekri H; Al Ghonaium A; Speckmann C; Fischer A; Mahlaoui N; Nichols KE; Grunebaum E; Al Zahrani D; Roifman CM; Boelens J; Davies EG; Cavazzana-Calvo M; Notarangelo L; Gaspar HB;
    Blood; 2012 Oct; 120(17):3615-24; quiz 3626. PubMed ID: 22791287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the field of hematopoietic stem cell-based therapies for inborn errors of immunity.
    Arnold DE; Pai SY
    Curr Opin Pediatr; 2023 Dec; 35(6):663-670. PubMed ID: 37732933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.
    Nishimura A; Aoki Y; Ishiwata Y; Ichimura T; Ueyama J; Kawahara Y; Tomoda T; Inoue M; Matsumoto K; Inoue K; Hiroki H; Ono S; Yamashita M; Okano T; Tanaka-Kubota M; Ashiarai M; Miyamoto S; Miyawaki R; Yamagishi C; Tezuka M; Okawa T; Hoshino A; Endo A; Yasuhara M; Kamiya T; Mitsuiki N; Ono T; Isoda T; Yanagimachi M; Tomizawa D; Nagasawa M; Mizutani S; Kajiwara M; Takagi M; Kanegane H; Imai K; Morio T
    J Clin Immunol; 2021 Jul; 41(5):944-957. PubMed ID: 33527309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
    Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M
    J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
    Wieduwilt MJ; Metheny L; Zhang MJ; Wang HL; Estrada-Merly N; Marks DI; Al-Homsi AS; Muffly L; Chao N; Rizzieri D; Gale RP; Gadalla SM; Cairo M; Mussetti A; Gore S; Bhatt VR; Patel SS; Michelis FV; Inamoto Y; Badawy SM; Copelan E; Palmisiano N; Kharfan-Dabaja MA; Lazarus HM; Ganguly S; Bredeson C; Diaz Perez MA; Cassaday R; Savani BN; Ballen K; Martino R; Wirk B; Bacher U; Aljurf M; Bashey A; Murthy HS; Yared JA; Aldoss I; Farhadfar N; Liu H; Abdel-Azim H; Waller EK; Solh M; Seftel MD; van der Poel M; Grunwald MR; Liesveld JL; Kamble RT; McGuirk J; Munker R; Cahn JY; Lee JW; Freytes CO; Krem MM; Winestone LE; Gergis U; Nathan S; Olsson RF; Verdonck LF; Sharma A; Ringdén O; Friend BD; Cerny J; Choe H; Chhabra S; Nishihori T; Seo S; George B; Baxter-Lowe LA; Hildebrandt GC; de Lima M; Litzow M; Kebriaei P; Hourigan CS; Abid MB; Weisdorf DJ; Saber W
    Blood Adv; 2022 Jan; 6(1):339-357. PubMed ID: 34547770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.